Glenmark's arm recalls 1,200 bottles of Trandolapril & Verapamil Hydrochloride extended-release tablets

28 Aug 2023 Evaluate

Glenmark Pharmaceuticals’ New Jersey-based arm -- Glenmark Pharmaceuticals Inc is recalling 1,200 bottles of Trandolapril and Verapamil Hydrochloride extended-release tablets. As per the latest Enforcement Report of the US health regulator USFDA, the affected lot has been manufactured at the Goa plant of the Mumbai-based drug firm and then supplied to Glenmark Pharmaceuticals Inc, USA.

Glenmark Pharmaceuticals Inc initiated the nationwide (US) Class III recall on August 14, 2023. As per the USFDA, a Class III recall is initiated in a ‘situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences’.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.


Glenmark Pharma Share Price

1970.75 -25.15 (-1.26%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×